Gilead Sciences Inc

S$170.73
SGD
Last updated on --.
24h volume6.41M
24h highest174.07 SGD
24h lowest170.70 SGD
24h Price movement-0.48%

GILD recent prices

24 Hours
-0.48%-S$0.82999
30 days
+5.74%+S$9.355
60 days
+0.09%+S$0.15323
90 days
-6.05%-S$11.11

Key data

Previous close171.56 SGD
Market cap207.19B SGD
Volume6.41M
P/E ratio17.610000
Dividend yield (TTM)0.02%
Dividend amount1.0471 SGD
Next ex-dividend date15 Jun 2026
Next payment date29 Jun 2026
EPS diluted (TTM)9.4746 SGD
Net income (FY)11.77B SGD
Revenue (FY)37.97B SGD
Last report date7 May 2026

About Gilead Sciences Inc

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
HeadquartersFOSTER CITY
Employees (FY)17.00K
Revenue per employee (FY)2.23M SGD
Net income per employee (FY)692.31K SGD
Listed onNasdaq
Official website

GILD conversion tables

GILDGILD
SGDSGD
0.5 GILD85.36 SGD
1 GILD170.73 SGD
5 GILD853.67 SGD
10 GILD1,707.34 SGD
SGDSGD
GILDGILD
0.5 SGD0.0029285 GILD
1 SGD0.0058571 GILD
5 SGD0.029285 GILD
10 SGD0.058571 GILD

FAQ

GILD is trading at S$170.73, -0.48% over the last 24 hours. Track live moves on the price chart at the top of this page.
The GILD stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. GILD is currently trading at S$170.73, -0.48% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on GILD price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. GILD's P/E ratio is currently 17.610000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from GILD; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against GILD's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Gilead Sciences Inc's market cap is currently 207.19B SGD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume6.41M
24h highest174.07 SGD
24h lowest170.70 SGD
24h Price movement-0.48%
GILDGILD
SGDSGD
Start trade with GILD Perpetual